W. Scott Campbell, MBA, PhD University of Nebraska Medical Center

Slides:



Advertisements
Similar presentations
Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Advertisements

Surgical Pathology of Wide Local Excision of Breast
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.
Introduction to Pathology. What is pathology Pathology is the scientific study of disease. In its broadest sense, it is the study of how the organs and.
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
Procedures used by CHTN
AJCC TNM Staging 7th Edition Breast Case #3
Faculty of Medicine - Benha University
Moving Toward Personalized Treatment for Gastric Cancer: Role of HER2 Testing Frédérique Penault-Llorca, MD, PhD Professor of Pathology Centre Jean Perrin.
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,
Piya Kiatisevi 1, Torsten Nielsen 2, Malcolm Hayes 2, Peter L Munk 3, Amy E LaFrance 4, Paul W Clarkson 4, Bassam A Masri 4 1 Orthopaedic Oncology Lerdsin.
SYB 1 Erin Gundersen MS IV. Breast Cancer Breast Cancer.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
Head and Neck MP/H Task Force Multiple Primary Rules
The Breast Clinic Index case Year 2 Michaelmas term.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
1 Head and Neck. 2 Equivalent Terms, Definitions, Charts, Tables and Illustrations Primary site –Do not code biopsy site.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
Pathology.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.
SNOMED CT and Surgical Pathology
Ultrasound breast core needle biopsy
Indications for Breast MR Imaging
Pancreatic Tumors: Diagnostic Patterns by 3D Gradient-Echo Post Contrast Magnetic Resonance Imaging with Pathologic Correlation  Khaled M. Elsayes, MD,
W. Scott Campbell, MBA, PhD James R. Campbell, MD
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.
Cancer Synoptic Worksheet Encoding Project
Volume 39, Issue 4, Pages (July 2015)
Fig. 4. Representative microscopic images of core needle biopsy specimens. A. Paucicellular fibrotic nodule with calcification shows few atypical follicular.
Hematology and Pathology Devices Panel Meeting October 22-23, 2009
H&E = hematoxylin and eosin
Ductal carcinoma in situ (DCIS)
 [P1]Can you put in the numbers here for specificity and NPV
SNOMED CT and Surgical Pathology
FDA Hematology and Pathology Devices Panel Meeting October 22-23, 2009
Patterns of ductal carcinoma in situ (DCIS)
What is Useful? Publishing Support for Precision Medicine
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Invasive breast cancer. A
IHTSDO Observables Project Group April 21, 2008 Evanston, Illinois
Ductal carcinoma in situ (DCIS)
History 58 year-old female presented with back pain and right toe numbness. Her past medical history was significant for hypertension, glaucoma and.
Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.
Is Ductal Carcinoma In Situ With “Possible Invasion” More Predictive of Invasive Carcinoma Than Pure Ductal Carcinoma In Situ?  Tal Arazi-Kleinman, MD,
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
INTERNATIONAL CONFERENCE
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Handling and Evaluation of Breast Cancer Biopsy
Patient 1. Patient 1. Axial T2 FLAIR (A) MR image demonstrates abnormal T2 FLAIR signal in the right lateral pons extending into the right trigeminal nerve.
Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes 
Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors  Geoffrey B. Johnson, MD, PhD, Marie Christine Aubry,
Volume 67, Issue 4, Pages (April 2005)
OF THE EUROPEAN ASSOCIATION OF UROLOGY
Extending OMOP CDM to Support Observational Cancer Research
Histopathologic examination of a specimen obtained from left lentiform nucleus by stereotactic biopsy. Histopathologic examination of a specimen obtained.
A, Recurrent neoplasm in patient 6.
Presentation transcript:

W. Scott Campbell, MBA, PhD University of Nebraska Medical Center Histopathology and Proposed Observable entity and evaluation procedure Model W. Scott Campbell, MBA, PhD University of Nebraska Medical Center

Surgical Pathology Overview University of Nebraska Medical Center Surgical Pathology Overview Case Clinical Findings (Diagnoses) Clinical Findings Specimen 1..n 1 Clinical Findings Blocks Clinical Findings Observations 1..n 1 Pathologist Examines Slides by Microscope with various stains Observations lead to Clinical Findings Other patient information Diagnoses rendered Slides 1..n 1

Typical Pathology Report University of Nebraska Medical Center Typical Pathology Report Final Diagnosis: RIGHT BREAST, VACUUM-ASSISTED NEEDLE CORE BIOPSY: - DUCTAL CARCINOMA IN SITU WITH EXTENSIVE PERIDUCTAL SCLEROSIS AND INFLAMMATION. - FOCUS SUSPICIOUS BUT NOT DIAGNOSTIC FOR MICROINVASION. - GROWTH PATTERN: SOLID. - NUCLEAR GRADE: HIGH. - NECROSIS: PRESENT. - MICROCALCIFICATION IN DCIS: YES. Microscopic Report: Performed Finding and observation Observations

Review of Common Histopathology Observations and Findings University of Nebraska Medical Center Review of Common Histopathology Observations and Findings Observation of morphology (Model helpful) Size of tumor (Model very helpful) Histologic grades? Possibility/Suspicion? Finding vs. Observation Situations…again!?!

Observation of morphology: Epithelial hyperplasia in breast biopsy University of Nebraska Medical Center Observation of morphology: Epithelial hyperplasia in breast biopsy |IS ABOUT| (Property type?) = 404684003|Clinical finding|: {363698007|Finding site|= 31737007|structure of small lactiferous ducts|, 116676008|Associated morphology|= 31390008|epithelial hyperplasia|}, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|), |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy| Ability to call out staining methods important

Observation: Measurement of tumor extent University of Nebraska Medical Center Observation: Measurement of tumor extent |IS ABOUT| = |PROPERTY TYPE| = 444740005|largest dimension of in situ neoplasm|, |INHERES IN| = 86616005|intraductal carcinoma, noninfiltrating|, |Scale| = 30766002|quantitative|, |Has value| = 1.7, |Units| = 258673006|mm|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|), |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Histologic Grade (Option 1) University of Nebraska Medical Center Histologic Grade (Option 1) |IS ABOUT| = 404684003|Clinical finding|: {363698007|Finding site|= 64633006| lactiferous duct structure|, 116676008|Associated morphology|= 86616005|intraductal carcinoma, noninfiltrating, no ICD-O subtype|, 47429007|Associated with|= 373399007|nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3|}, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) , |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Histologic Grade (Option 2) University of Nebraska Medical Center Histologic Grade (Option 2) |IS ABOUT| = 404684003|Clinical finding| = 373399007|nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3|, |INHERES IN| = 86616005|intraductal carcinoma, noninfiltrating|, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Suspicion as an Observation University of Nebraska Medical Center Suspicion as an Observation |IS ABOUT| = 404684003|Clinical finding|: {363698007|Finding site|= 64633006| lactiferous duct structure|, 116676008|Associated morphology|= 82711006|infiltrating duct carcinoma|}, |Scale| = 26716007|qualitative|, |Has value| = 373068000|undetermined|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy| 42425007|equivocal| ?

University of Nebraska Medical Center Diagnostic Level Statement: Example: Ductal Carcinoma in situ suspicious for microinvasion 243796009|situation with explicit context|: {408729009|finding context| = 415684004|suspected|, 410510008|temporal context value| = 410585006|current – unspecified|, 408732007|subject relationship context| = 410604004|subject of record, 246090004|associated finding|= 404684003|clinical finding|: {363698007|finding site| = 64633006|lactiferous duct structure|, 116676008|associated morphology| = 82711006|infiltrating duct carcinoma|} }

University of Nebraska Medical Center Conclusions Clarification of acceptable attribute/value domains and ranges Continue to struggle with descriptive language for architectural features (pre-diagnostic or importance to be determined) Suspicion and probability of the Clinical Finding (diagnostic lines) Binding to synoptic reports

University of Nebraska Medical Center Thank you

University of Nebraska Medical Center